2.2. Challenges and Limitations to Oversight Andres Soosaar, Estonia.

Slides:

Advertisements

Similar presentations

1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team.

Advertisements

Group 1.3 Relationships between RECs in multi-centre, international studies –problems and solutions.

Ethics of Mental Health Research. Q1: ways in which mental health differs Definition of mental illness is problematic. Terminology is very broad and inconsistent.

The Execution and Management of a Complex Clinical Trial Elizabeth K. Walsh, RN ECTSS 2013 Conflicts of Interest Advisory Board for TAVR Administrators.

Research involving adults lacking the capacity to consent Legal, ethical and practical issues Dr Mikey Dunn Senior Research Associate in Health and Social.

Chicken Soup for the Busy Coordinator

The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)

Safety Reporting IN Clinical Trials

What CQC do CQC are the health and social care regulator for England CQC register and monitor all health and social care providers in the country to ensure.

A Blueprint For Clinical Research: Standard Operating Procedures

Reporting Unanticipated Problems Involving Risk to Subjects or Others and Adverse Events WFUHS Policy/Procedure Effective Date 6/1/07 Wendy Murray Monitoring.

Audit Committee and Corporate Governance. The European Confederation of Institutes of Internal Auditing (ECIIA) Founded in 1982 Confederation of 32 countries.

Audit Committee in Albania Legal framework Law 9226 /2006 “On banks in Republic of Albania” Law 9901/2008 “On entrepreneurs and commercial companies” Corporate.

GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.

Use of Children as Research Subjects What information should be provided for an FP7 ethical review?

John Naim, PhD Director Clinical Trials Research Unit

Managing Sponsorship Research Services University of Oxford.

Research Ethics-Integrity-Governance. University Initiative:The Catalyst? ‘02 Good Research Practice Standards & Procedure to Investigate Potential Research.

Study Team Members and Responsibilities Chicken Soup for the Busy Coordinator (April 2010)

Clinical Research Conference 2012 Legal, Ethical, and Social Dimensions of Clinical Research Takis Vidalis, Ph. D., Hellenic National Bioethics Commission.

PRESENTING A PROTOCOL AN IRB INFOSHORT FEBRUARY 2013.

Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?

by Joint Commission International (JCI)

International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.

Equity Housing Group Risk Management. 05 August 2002 © MazarsEquity Housing Group: Risk Management 2 Agenda Introduction: what is Risk Management? The.

Gil Harari Statistical considerations in clinical trials

Module 3. Session DCST Clinical governance

A S Nanivadekar Introduction to GCP. A S Nanivadekar Outline Definition and scope Definition and scope Purpose of clinical research Purpose of clinical.

Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,

THE ROLE OF DSMB’s in CLINICAL RESEARCH Data and Safety Monitoring Monitoring.

1 Safety Culture Survey Marty White November 2, 2009.

Implementing and Auditing Ethics Programs

ECOSOC GLOBAL PREPARATORY MEETING OF THE ANNUAL MINISTERIAL REVIEW(AMR) 28 APRIL 2011.

Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.

Institutional Review Board for Human Subject Research: Does Your Research Need One? Merle Rosenzweig Michael Unsworth.

Challenges: Monitoring of Research: The Options Robert Bortolussi and Diann Nicholson IWK Health Centre, Dalhousie University, Halifax NS.

The Board of Director’s Role in Diversity Implementation Reatha Clark King PhD COLLOQUIUM ON GLOBAL DIVERSITY GLOBAL SUMMIT OF WOMEN THE WORLD BANK February.

Research Governance Dr. Sheila Francis

Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.

Gitanjali 1 WHO sponsored workshop on Good Clinical Practice for Ethics Committee Members an orientation to the workshopB.Gitanjali Organizing Secretary.

Joint meeting of Baltic HRECs Riga, May 9-10, 2008 Some Remarks on Biomedical Research Ethics in Estonia Andres Soosaar Universtity of Tartu.

Identifying and recruiting patients for clinical trials in the future: a pharma perspective Rob Thwaites EC/EFPIA Workshop on ” Primary and secondary use.

Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.

Office of Human Research Protection Georgia Health Sciences University.

PATIENT CENTRED CARE Empowering patients to become active participants in their care.

VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs.

VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs September.

Communication of the Strategic and Annual Audit Plan (Dutch situation)

Russian Cooperative compliance program – Tax monitoring Ivan Rodionov Head of Tax Performance Advisory, Russia and the CIS.

Introduction to Research Governance, Ethics and Integrity Mrs April Lockyer Senior Research Policy Officer (Governance and Integrity)

Quality Metrics of Performance of Research Ethics Committees Cristina E. Torres, PhD FERCAP Coordinator.

The IRB and Human Subjects Research Protection Eric Felde, CIP Research Compliance Consultant Office of Research Compliance Indiana University.

PRAGMATIC Study Designs: Elderly Cancer Trials

Audit on herbal study protocols reviewed by an Ethics Review Committee of a Western Medical Institution Wanigatunge CA, Warnacula G, Prathapan S Ethics.

Patient Safety Global or Country Specific ? David Marx.

Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.

Issues that Matter Notification and Escalation

CLINICAL TRIALS.

RISK MANAGEMENT SYSTEM

Nordic Cooperation on Ethical Review Procedures Nordforsk – nordic trial alliance MIKA SCHEININ

Patricia M. Alt, Ph.D. Dept. of Health Science Towson University

CONDUCTING THE TRIAL AT

What is a Data and Safety Monitoring Plan and how do I get one?

Good Clinical Practice (GCP) requirements for ANODE

Good Clinical Practice

Corporate Governance Corporate Governance also plays an important role in maintaining corporate integrity and managing the risk of corporate fraud, combating.

Delegation Compliance Specialist

Safety and Surgical Checklists

Update on the OIG’s Investigations Involving Clinical Research

Consent and eligibility for Clinical Trials: Learning Burst 4

Presentation transcript:

2.2. Challenges and Limitations to Oversight Andres Soosaar, Estonia

General positions Monitoring and auditing are different activities: the audit is more legally estimated concept, monitoring is rather more flexible one with different practices Regular (annual, quarterly) reporting of different aspects about projects is common practice; Clinical trials and other biomedical research have quite different practices of oversight.

Research subjects and REC Very small feedback about problems in research projects from research subjects despite of possibility to do that; Research subjects need to know contact information of the REC approved the project to inform about of misconduct of researchers.

Informed consent issue RECs have little information about the real informed consent process in reviewed projects, but there is not easy and efficient way to follow the consent procedure by REC REC mainly trust researchers in realizing informed consent procedure after approval of the project In case of high risk study REC could perform survey on limited group of participants how efficient has been the consent procedure or Have RECs some internal list of most complicated issues which should be carefully managed in informed consent process by researchers? In some countries, e.g. China, there are practices that REC members monitor some steps of the study (in cases of complicated or burden rich design of a study) on site.

Adverse events REC has crucial role to work with safety information (Costa Rica) In several countries it is not the task of REC at all. Researchers should present to REC with project application safety criteria to stop or continue project.